DVRd in the Treatment of Patients With Newly Diagnosed Double-hit Multiple Myeloma

Trial Details

NCT ID

NCT06158269

Phase

PHASE2

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Status

RECRUITING

Cancer Type

Newly Diagnosed Multiple Myeloma

Interventions

• DVRd

Locations (sample)

• Tianjin, China|39.14222,117.17667

Key Eligibility Criteria

• Voluntarily signing the Informed Consent Form (ICF).
• Age: ≥ 18 years old and \< 70 years old.
• Newly diagnosed MM according to International Myeloma Working Group (IMWG) criteria, with at least one measurable disease: The serum M protein dete…
• At least two high-risk cytogenetic abnormalities: t(4;14), t(14;16), t(14;20), del(17p), gain/amp(1q) (the threshold for copy number variation is 2…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.